can i stay on .25 semaglutide For patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor agonist, is approved for weight management as a once-weekly subcutaneous injection. In a previous trial, oral at a dose of 50 mg The Ozempic Pill Has Arrived.
Description
Accessed August 10, 2025

Source: Wellcare GLP-1 Coverage Guide
Not for human consumption, diagnostic, or therapeutic use

Their affordable, accessible care allowed me to continue my journey with personalized health plans, unlimited provider visits, and nutrition support